Showing results (441-450 of 601) with videos related to
Sort By:
Pageof 61
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2019
pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosisDavid Kremer, Joel Gruchot, Vivien Weyers, et al.The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.Journal of Neurology|November 10, 2014
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTOREMichael Kaufman, Bruce A C Cree, Jerome De Sèze, et al.Frontiers in Immunology|June 15, 2026
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosisDerrick Robertson, Enrique Alvarez, Lawrence Steinman, et al.Neurology|October 11, 2015
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFITKassandra L Munger, Kathryn C Fitzgerald, Mark S Freedman, et al.American Journal of Human Genetics|January 25, 2003
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathyKristien Verhoeven, Peter De Jonghe, Katrien Coen, et al.BMC Infectious Diseases|December 1, 2019
Meningitis gone viral: description of the echovirus wave 2013 in GermanyJonas Graf, Christian J Hartmann, Helmar C Lehmann, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 29, 2011
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trialDouglas S Goodin, Hans-Peter Hartung, Paul O'Connor, et al.Glia|September 24, 2017
Human mesenchymal factors induce rat hippocampal- and human neural stem cell dependent oligodendrogenesisJanusz J Jadasz, Lena Tepe, Felix Beyer, et al.The New England Journal of Medicine|January 26, 2007
Lack of association between antimyelin antibodies and progression to multiple sclerosisJens Kuhle, Christoph Pohl, Matthias Mehling, et al.Pageof 61